A synthetic covalent ligand of the C/EBPβ transactivation domain inhibits acute myeloid leukemia cells.

MLA

Abdel Ghani, Luca, et al. “A Synthetic Covalent Ligand of the C/EBPβ Transactivation Domain Inhibits Acute Myeloid Leukemia Cells.” Cancer Letters, vol. 530, Apr. 2022, pp. 170–80. EBSCOhost, https://doi.org/10.1016/j.canlet.2022.01.024.

APA

Abdel Ghani, L., Yusenko, M. V., Frank, D., Moorthy, R., Widen, J. C., Dörner, W., Khandanpour, C., Harki, D. A., & Klempnauer, K.-H. (2022). A synthetic covalent ligand of the C/EBPβ transactivation domain inhibits acute myeloid leukemia cells. Cancer Letters, 530, 170–180. https://doi.org/10.1016/j.canlet.2022.01.024

Chicago

Abdel Ghani, Luca, Maria V Yusenko, Daria Frank, Ramkumar Moorthy, John C Widen, Wolfgang Dörner, Cyrus Khandanpour, Daniel A Harki, and Karl-Heinz Klempnauer. 2022. “A Synthetic Covalent Ligand of the C/EBPβ Transactivation Domain Inhibits Acute Myeloid Leukemia Cells.” Cancer Letters 530 (April): 170–80. doi:10.1016/j.canlet.2022.01.024.